173 related articles for article (PubMed ID: 27493974)
21. Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients.
González-Calle V; Mateos MV
Eur J Intern Med; 2018 Dec; 58():57-63. PubMed ID: 29907380
[TBL] [Abstract][Full Text] [Related]
22. The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.
Foglietta M; Castella B; Mariani S; Coscia M; Godio L; Ferracini R; Ruggeri M; Muccio V; Omedé P; Palumbo A; Boccadoro M; Massaia M
Haematologica; 2014 Oct; 99(10):1605-10. PubMed ID: 24972771
[TBL] [Abstract][Full Text] [Related]
23. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Willrich MAV; Murray DL; Kyle RA
Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
[TBL] [Abstract][Full Text] [Related]
24. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders.
Raja KR; Kovarova L; Hajek R
Br J Haematol; 2010 May; 149(3):334-51. PubMed ID: 20201947
[TBL] [Abstract][Full Text] [Related]
25. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.
Głowala-Kosińska M; Chwieduk A; Nieckula J; Saduś-Wojciechowska M; Grosicki S; Rusin A; Nowara E; Giebel S
Eur J Haematol; 2013 Aug; 91(2):122-8. PubMed ID: 23679234
[TBL] [Abstract][Full Text] [Related]
26. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.
Bosseboeuf A; Seillier C; Mennesson N; Allain-Maillet S; Fourny M; Tallet A; Piver E; Lehours P; Mégraud F; Berthelot L; Harb J; Bigot-Corbel E; Hermouet S
Front Immunol; 2020; 11():854. PubMed ID: 32536913
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and outcomes in biclonal gammopathies.
Mullikin TC; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lin Y; Dingli D; Go RS; Hayman SR; Zeldenrust SR; Russell SJ; Lust JA; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
Am J Hematol; 2016 May; 91(5):473-5. PubMed ID: 26840395
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.
Corso A; Castelli G; Pagnucco G; Lazzarino M; Bellio L; Klersy C; Bernasconi C
Haematologica; 1997; 82(1):43-6. PubMed ID: 9107081
[TBL] [Abstract][Full Text] [Related]
30. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
[TBL] [Abstract][Full Text] [Related]
31. T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.
San Miguel JF; Caballero MD; Gonzalez M
Am J Hematol; 1985 Nov; 20(3):267-73. PubMed ID: 3933332
[TBL] [Abstract][Full Text] [Related]
32. [OKT-8+ suppressor T-lymphocytes are increased in patients with stable multiple myeloma].
Ludwig C; Hicks MJ; Pena D; Durie BG
Schweiz Med Wochenschr; 1983 Oct; 113(40):1451-4. PubMed ID: 6227989
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
34. Activity of aldehyde dehydrogenase in B-cell and plasma cell subsets of monoclonal gammopathy patients and healthy donors.
Všianská P; Bezděková R; Kryukov F; Almáši M; Pour L; Penka M; Hájek R; Říhová L
Eur J Haematol; 2017 Jan; 98(1):19-25. PubMed ID: 27199264
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal gammopathies in a Moroccan military hospital.
Ouzzif Z; Doghmi K; Bouhsain S; Dami A; El Machtani S; Tellal S; Messaoudi N; Mikdame M; El Maataoui A
Rheumatol Int; 2012 Oct; 32(10):3303-7. PubMed ID: 21881989
[TBL] [Abstract][Full Text] [Related]
36. Changes of circulating CD4(+)CD25(+)CD127(low) regulatory T cells in patients with acute coronary syndrome and its significance.
Liu M; Xu LJ; Wu JX
Genet Mol Res; 2015 Dec; 14(4):15930-6. PubMed ID: 26662384
[TBL] [Abstract][Full Text] [Related]
37. Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases. Cooperative Group for the Study and Treatment of Multiple Myeloma.
Ucci G; Riccardi A; Luoni R; Ascari E
J Intern Med; 1993 Aug; 234(2):165-73. PubMed ID: 8340739
[TBL] [Abstract][Full Text] [Related]
38. The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma.
Steiner N; Hajek R; Sevcikova S; Borjan B; Untergasser G; Göbel G; Gunsilius E
Anticancer Res; 2018 Sep; 38(9):5087-5092. PubMed ID: 30194153
[TBL] [Abstract][Full Text] [Related]
39. High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma.
Terpos E; Christoulas D; Kastritis E; Bagratuni T; Gavriatopoulou M; Roussou M; Papatheodorou A; Eleutherakis-Papaiakovou E; Kanellias N; Liakou C; Panagiotidis I; Migkou M; Kokkoris P; Moulopoulos LA; Dimopoulos MA
Blood Cancer J; 2016 Oct; 6(10):e482. PubMed ID: 27716740
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.
Scudla V; Petrova P; Minarik J; Pika T; Bacovsky J
Neoplasma; 2011; 58(6):499-506. PubMed ID: 21895403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
